Riskpilot← Back to searchSign inGet full accessHEMO INVEST AS
ASActiveOrg 989101501Årstadveien 8, 5009 BergenRental and operating of own or leased real estate · NACE 6820Est. 20050 employees
Revenue 2024
NOK 0
EBITDA margin
—
+76% vs 2023
Equity ratio
99.3%
Financial strength
Net profit 2024
NOK -43,4M
-160% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -61K | +76% |
| Net profit | NOK -43,4M | -160% |
| Total assets | NOK 134,1M | -24% |
| Equity | NOK 133,1M | -25% |
| Employees | 0 | — |
Legal name
HEMO INVEST AS
Org number
989101501
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
31. desember 2005
Share capital
NOK 1 320 480
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investeringsvirksomhet, herunder kjøp og salg av aksjer, andeler og fast eiendom og annen virksomhet som står i forbindelse med formålet.
Address
Årstadveien 8, 5009 Bergen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 11 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −41 | −79 | −52 | −255 | −61 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −41 | −79 | −52 | −255 | −61 |
| Net financials | −75 868 | −12 074 | 3 095 | 72 216 | −42 594 |
| Profit before tax | −75 910 | −12 153 | 3 043 | 71 962 | −42 655 |
| Tax | −3 | −0 | −0 | −0 | 705 |
| Net profit | −75 907 | −12 153 | 3 043 | 71 962 | −43 360 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 113 651 | 101 498 | 104 541 | 176 503 | 134 054 |
| Equity | 113 584 | 101 431 | 104 475 | 176 436 | 133 076 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 67 | 67 | 67 | 67 | 978 |
| Total debt | 67 | 67 | 67 | 67 | 978 |
EBITDA margin
-6141000.0%
This company
15.8%
Market median
-38867189% vs market
20202024
Equity ratio
99.3%
This company
38.2%
Market median
+160% vs market
20202024
Return on equity
-32.6%
This company
18.4%
Market median
-277% vs market
20202024
Net profit margin
-4336026700.0%
This company
8.1%
Market median
-53531193927% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HO Contact Person | Contact Person | 2005 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2015 | |
| Board of Directors | 2015 | |
| Board of Directors | 2015 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HEMO INVEST AS 
Viken Shipping AsBoard members of HEMO INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Olav Lindal | Contact Person | 0 companies |
| Evy Greve | Chairman | 0 companies |
| Ole Ødegård Lindal | Board of Directors | 0 companies |
| Helene Greve Lindal | Board of Directors | 0 companies |